These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1646 related items for PubMed ID: 1295440

  • 1. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH.
    Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
    [Abstract] [Full Text] [Related]

  • 2. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA, Custer MC, Rosenberg SA, Lotze MT.
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [Abstract] [Full Text] [Related]

  • 3. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM, Zhu HG, Anderer FA.
    Anticancer Res; 1993 Apr; 13(4):923-30. PubMed ID: 8352560
    [Abstract] [Full Text] [Related]

  • 4. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T, Nakamura Y, Takeuchi Y, Tokuda Y, Iwasawa M, Kawasaki A, Okumura K, Habu S.
    J Immunol; 1992 Jan 01; 148(1):285-91. PubMed ID: 1345787
    [Abstract] [Full Text] [Related]

  • 5. In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2.
    Schomburg A, Menzel T, Körfer A, Heer G, Dallmann I, Kirchner H, Poliwoda H, Atzpodien J.
    Nat Immun; 1992 Jan 01; 11(3):133-43. PubMed ID: 1392401
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
    Damle NK, Doyle LV.
    Lymphokine Res; 1989 Jan 01; 8(2):85-97. PubMed ID: 2525210
    [Abstract] [Full Text] [Related]

  • 13. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Izquierdo M, López-Botet M.
    J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071
    [Abstract] [Full Text] [Related]

  • 14. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K, Tilden AB, Balch CM.
    J Immunol; 1986 May 15; 136(10):3910-5. PubMed ID: 3084648
    [Abstract] [Full Text] [Related]

  • 15. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R.
    Cancer Res; 1990 Apr 15; 50(8):2363-70. PubMed ID: 2107973
    [Abstract] [Full Text] [Related]

  • 17. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L.
    Eur J Immunol; 1994 Oct 15; 24(10):2294-8. PubMed ID: 7925558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S, Cantoni C, Ciccone E, Biassoni R, Prigione I, Bottino C, Venzano P, Moretta L.
    Eur J Immunol; 1991 Sep 15; 21(9):1981-7. PubMed ID: 1832383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 83.